Cargando…

Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET–Based Salvage Radiotherapy for Recurrent Prostate Cancer

IMPORTANCE: Prostate-specific antigen membrane positron-emission tomography (PSMA-PET) is increasingly used to guide salvage radiotherapy (sRT) after radical prostatectomy for patients with recurrent or persistent prostate cancer. OBJECTIVE: To develop and validate a nomogram for prediction of freed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zamboglou, Constantinos, Peeken, Jan C., Janbain, Ali, Katsahian, Sandrine, Strouthos, Iosif, Ferentinos, Konstantinos, Farolfi, Andrea, Koerber, Stefan A., Debus, Juergen, Vogel, Marco E., Combs, Stephanie E., Vrachimis, Alexis, Morganti, Alessio Giuseppe, Spohn, Simon K. B., Shelan, Mohamed, Aebersold, Daniel M., Grosu, Anca-Ligia, Ceci, Francesco, Henkenberens, Christoph, Kroeze, Stephanie G. C., Guckenberger, Matthias, Fanti, Stefano, Belka, Claus, Bartenstein, Peter, Hruby, George, Scharl, Sophia, Wiegel, Thomas, Emmett, Louise, Arnoux, Armelle, Schmidt-Hegemann, Nina-Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208140/ https://www.ncbi.nlm.nih.gov/pubmed/37219907 http://dx.doi.org/10.1001/jamanetworkopen.2023.14748

Ejemplares similares

PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
por: Solomonidou, Nantia, et al.
Publicado: (2023)

Combining (68)Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study
por: Kirste, Simon, et al.
Publicado: (2021)

High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome
por: Strouthos, Iosif, et al.
Publicado: (2021)

Narrative Review of High-Dose-Rate Interstitial Brachytherapy in Primary or Secondary Liver Tumors
por: Karagiannis, Efstratios, et al.
Publicado: (2022)

Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [(68)Ga]PSMA-PET-guided metastasis-directed therapy
por: Vogel, Marco M. E., et al.
Publicado: (2020)

A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic Fossa
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2021)

Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
por: Oehus, Ann-Kathrin, et al.
Publicado: (2020)

The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis
por: Spohn, Simon K. B., et al.
Publicado: (2022)

PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives
por: Zschaeck, Sebastian, et al.
Publicado: (2018)

A clinical evaluation of the performance of five commercial artificial intelligence contouring systems for radiotherapy
por: Doolan, Paul J., et al.
Publicado: (2023)

Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries: A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO)
por: Shelan, Mohamed, et al.
Publicado: (2021)

Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair Analysis
por: Schmidt Hegemann, Nina-Sophie, et al.
Publicado: (2020)

Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
por: Spohn, Simon K. B., et al.
Publicado: (2023)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

PO-1885 Evaluation of a hybrid 3DCRT-VMAT technique for free breathing whole breast RT during COVID-19
por: Antorkas, G., et al.
Publicado: (2021)

Patterns-of-Care Analysis for Radiotherapy of Elderly Head-and-Neck Cancer Patients: A Trinational Survey in Germany, Austria and Switzerland
por: Haehl, Erik, et al.
Publicado: (2022)

Isotropic Expansion of the Intraprostatic Gross Tumor Volume of Primary Prostate Cancer Patients Defined in MRI—A Correlation Study With Whole Mount Histopathological Information as Reference
por: Kramer, Maria, et al.
Publicado: (2020)

Impact of a low FODMAP diet on the amount of rectal gas and rectal volume during radiotherapy in patients with prostate cancer – a prospective pilot study
por: Schaefer, Christian, et al.
Publicado: (2020)

Radiotherapy in nodal oligorecurrent prostate cancer
por: Pinkawa, Michael, et al.
Publicado: (2021)

First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments
por: Combs, Stephanie E., et al.
Publicado: (2020)

Ultrahypofractionation of localized prostate cancer: Statement from the DEGRO working group prostate cancer
por: Wolf, Frank, et al.
Publicado: (2020)

PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial
por: Zamboglou, Constantinos, et al.
Publicado: (2021)

Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme
por: Chatzikonstantinou, Georgios, et al.
Publicado: (2019)

Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases
por: Müller, Arndt-Christian, et al.
Publicado: (2022)

Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies
por: Spohn, Simon K.B., et al.
Publicado: (2021)

Comparison of Manual and Semi-Automatic [(18)F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference
por: Spohn, Simon K. B., et al.
Publicado: (2020)

The impact of the co-registration technique and analysis methodology in comparison studies between advanced imaging modalities and whole-mount-histology reference in primary prostate cancer
por: Zamboglou, Constantinos, et al.
Publicado: (2021)

Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients
por: Rühle, Alexander, et al.
Publicado: (2022)

Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters
por: Marinescu, Ioana M., et al.
Publicado: (2022)

Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy
por: Rühle, Alexander, et al.
Publicado: (2023)

Recent advances of PET imaging in clinical radiation oncology
por: Unterrainer, M., et al.
Publicado: (2020)

Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients
por: Spohn, S. K. B., et al.
Publicado: (2022)

Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment
por: Hegemann, Nina-Sophie, et al.
Publicado: (2016)

Surviving Elderly Patients with Head-and-Neck Squamous Cell Carcinoma—What Is the Long-Term Quality of Life after Curative Radiotherapy?
por: Rühle, Alexander, et al.
Publicado: (2021)

Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity
por: Fritz, Corinna, et al.
Publicado: (2018)

Einfluss einer adjuvanten Strahlentherapie im Vergleich zur „Early-salvage-Strahlentherapie“ auf die Letalität von Männern mit einem hohen Rezidivrisiko nach radikaler Prostatektomie wegen Prostatakarzinom
por: Spohn, Simon K. B., et al.
Publicado: (2021)

10-Jahres-Letalität, Krankheitsprogress und behandlungsassoziierte Nebenwirkungen bei Männern mit lokalisiertem Prostatakarzinom aus der randomisierten, kontrollierten ProtecT-Studie, analysiert nach erhaltener Therapie
por: Spohn, Simon K. B., et al.
Publicado: (2021)

Das Rezidivmuster nach perkutaner Strahlentherapie mit und ohne zusätzliche fokale Dosiseskalation innerhalb der randomisierten FLAME-Studie für das lokale Prostatakarzinom
por: Spohn, Simon K. B., et al.
Publicado: (2022)

Intraindividual comparison between (68)Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients
por: Spohn, Simon, et al.
Publicado: (2020)

Low-dose radiotherapy for painful osteoarthritis of the elderly: A multicenter analysis of 970 patients with 1185 treated sites
por: Rühle, Alexander, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_61o07ak9heal69m5nsktpimf8c